Nosca-Méréprine (Noscapine Hydrochloride Monohydrate)

Noscapine Hydrochloride Monohydrate, the active ingredient in Nosca-Méréprine, is an antitussive presented as an oral dosage form for oral use. It suppresses cough in adults and children with acute or chronic respiratory irritation.

GNH USA supplies Nosca-Méréprine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nosca-Méréprine is used to alleviate cough by acting on the central cough reflex pathway. - Acute cough: reduces the frequency and intensity of coughing episodes. - Chronic cough: provides symptomatic relief for persistent cough lasting more than eight weeks. - Cough associated with respiratory infections: helps control irritation‑driven cough during viral or bacterial upper‑respiratory tract infections.

Nosca-Méréprine may be associated with a range of adverse reactions, which are categorised by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: transient light‑headedness. - Drowsiness: mild sedation, especially at higher doses. - Gastrointestinal discomfort: abdominal cramping or mild diarrhea. - Headache: occasional tension‑type headache. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or swelling of the face and throat. - Anaphylaxis: rare but potentially life‑threatening hypersensitivity. - Hepatic dysfunction: elevated liver enzymes in susceptible individuals. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hematologic abnormalities: unexplained bruising or bleeding. - Respiratory depression: extremely rare, usually with concomitant CNS depressants.

When prescribing Nosca-Méréprine, clinicians should consider several safety aspects. - Assess renal function: adjust use in patients with severe renal impairment. - Monitor hepatic status: avoid in individuals with known liver disease. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Caution with CNS depressants: increased risk of sedation or respiratory depression. - Use in pregnancy only if clearly needed: limited data on fetal safety. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nosca-Méréprine can interact with other medicines, requiring attention to the interaction strength.

Major Interactions (Avoid): - Concurrent use with other central nervous system depressants (e.g., opioids, benzodiazepines): may potentiate sedation and respiratory depression. - Combination with other antitussive agents (e.g., dextromethorphan): risk of additive central effects.

Moderate Interactions (Monitor Closely): - CYP450 substrates: noscapine may modestly inhibit certain enzymes, potentially altering plasma levels of drugs such as warfarin. - Antihistamines: may increase drowsiness. - Alcohol: can enhance central nervous system depression.